GlassScriptPhysician profile
Adi Katz
NPI 1437488335
$4,829.48
in general payments reported to CMS, 2019-2025
8 companies · $73.13 in 2025
The $73.13 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.45 · 2021: $190 · 2022: $175 · 2023: $4,159 · 2024: $135 · 2025: $73.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Travel and Lodging: $445 · Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Travel and Lodging | $444.71 |
| Food and Beverage | $322.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $4,123.74 | 2023 | |
| Astellas Pharma US INC | $174.98 | 2022 | |
| Biom'Up France Sas | $139.08 | 2021 | |
| Hologic Sales and Service, LLC | $136.61 | 2024-2025 | Acessa Provu System |
| Coopersurgical, INC. | $97.45 | 2019 | |
| Meditrina | $71.30 | 2024 | |
| Medtronic, INC. | $51.13 | 2021 | |
| Sumitomo Pharma America, INC. | $35.19 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adi Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.